Kim Kelderman

Insider Reports History

Location
614 Mckinley Place Ne, Minneapolis, MN
Signature
/s/ Thomas Fistek for Kim Kelderman by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kim Kelderman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIO-TECHNE Corp Chief Executive Officer, Director Stock Options (Right to Buy) 90.4K $3.37M $48.75 Aug 15, 2025 Direct
BIO-TECHNE Corp Chief Executive Officer, Director Common Stock 51K $2.73M $53.60 Aug 15, 2025 Direct
BIO-TECHNE Corp Chief Executive Officer, Director Performance Restricted Stock Units 70.7K $2.5M $48.75 Aug 15, 2025 Direct
BIO-TECHNE Corp Chief Executive Officer, Director Performance Stock Options (Right to Buy) 25.9K $1.26M $48.75 Aug 15, 2025 Direct
BIO-TECHNE Corp Chief Executive Officer, Director Restricted Stock Units 35.4K $1.25M $48.75 Aug 15, 2025 Direct
BIO-TECHNE Corp Chief Executive Officer, Director Stock Option (Right to Buy) 25.9K $0 $48.75 Aug 15, 2025 Direct
CONMED Corp Director Common Stock 0 $0 $53.07 Sep 8, 2025 Direct
CONMED Corp Director Options To Purchase Common Stock 6.23K Sep 8, 2025 Direct
CONMED Corp Director RSUs (Restricted Stock Units) 500 Sep 8, 2025 Direct

Insider Reports Filed by Kim Kelderman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CNMD CONMED Corp Sep 8, 2025 2 $0 4 Sep 9, 2025 Director
CNMD CONMED Corp Sep 8, 2025 0 $0 3 Sep 9, 2025 Director
TECH BIO-TECHNE Corp Aug 15, 2025 6 -$231K 4 Aug 19, 2025 Chief Executive Officer, Director
TECH BIO-TECHNE Corp Jul 22, 2025 3 -$183K 4 Jul 24, 2025 Chief Executive Officer, Director
TECH BIO-TECHNE Corp Jul 15, 2025 3 -$91.7K 4 Jul 17, 2025 Chief Executive Officer, Director
TECH BIO-TECHNE Corp Jan 27, 2025 4 -$530K 4 Jan 29, 2025 Chief Executive Officer, Director
TECH BIO-TECHNE Corp Nov 1, 2024 1 -$183K 4 Nov 5, 2024 Chief Executive Officer, Director
TECH BIO-TECHNE Corp Aug 29, 2024 2 $99.9K 4 Sep 3, 2024 Chief Executive Officer, Director
TECH BIO-TECHNE Corp Aug 15, 2024 3 $0 4 Aug 19, 2024 Chief Executive Officer, Director
TECH BIO-TECHNE Corp Jul 31, 2024 3 -$249K 4 Aug 2, 2024 Chief Executive Officer, Director
TECH BIO-TECHNE Corp Nov 1, 2023 3 $0 4 Feb 5, 2024 Chief Operating Officer
TECH BIO-TECHNE Corp Nov 1, 2023 2 $0 4 Nov 3, 2023 Chief Operating Officer
TECH BIO-TECHNE Corp Aug 24, 2023 2 $100K 4 Aug 28, 2023 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Aug 15, 2023 2 $0 4/A Dec 14, 2023 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Aug 5, 2023 3 -$340K 4 Aug 8, 2023 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Aug 23, 2022 2 $100K 4 Aug 25, 2022 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Aug 15, 2022 3 $0 4 Aug 17, 2022 PRES. DIAGNOSTICS & GENOM
TECH BIO-TECHNE Corp Aug 7, 2022 3 -$465K 4 Aug 9, 2022 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Feb 8, 2022 2 $300K 4 Feb 10, 2022 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Nov 19, 2021 4 -$177K 4 Nov 23, 2021 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Sep 22, 2021 1 -$435K 4 Sep 24, 2021 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Aug 6, 2021 6 -$419K 4 Aug 10, 2021 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Jun 9, 2021 1 -$351K 4 Jun 11, 2021 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp May 25, 2021 1 -$358K 4 May 27, 2021 Pres. Diagnostics & Genom